CLINICAL ROLE -
CDC's ACIP Recommends Expanded HPV Vaccine Age Range for Some
The advisory board voted unanimously on Wednesday to recommend HPV vaccines for people through age 26.
Read More
FDA OKs Avatrombopag for Adults with Chronic Immune Thrombocytopenia
Officials with the FDA have approved Dova Pharmaceuticals’ supplemental New Drug Application (sNDA) for expanding the use of avatrombopag (Doptelet).
FDA Expands Use of Avatrombopag for Adults with Chronic Immune Thrombocytopenia
Avatrombopag was previously approved by the agency for treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure.
Topical Ruxolitinib Improves Vitiligo Severity in Phase 2 Study
Data from a phase 2 study demonstrated that topical ruxolitinib cream significantly improved repigmentation of facial lesions in adults with vitiligo.
Trending News Today: FDA Declines Approval to Drug for Rare Genetic Disorder
Top news of the day from across the health care landscape.
FDA OKs Dupilumab for Chronic Rhinosinusitis with Nasal Polyps
CRSwNP often occurs with severe asthma and requires systemic steroids or nasal surgery, the current standard of care.
Dupilumab Approved for Chronic Rhinosinusitis with Nasal Polyps
Dupilumab (Dupixent) is the first biologic medicine approved for inadequately controlled chronic rhinosinusitis with nasal polyposis.
Audit Suggests PBM Drug Pricing Practices May Lead to Higher Health Care Costs
To date, the Ohio audit is the first comprehensive review of PBM practices and incorporated 39 million drug transactions, the authors said.
Empagliflozin Earns FDA Fast Track Designation for Chronic Heart Failure
The drug is earned the designation for reducing the risk of cardiovascular death and hospitalization for heart failure in people with chronic heart failure.
Lawmakers, Pharmacy Groups Urge DIR Fee Reform Despite Exclusion from CMS Rule
The recently-finalized CMS drug pricing rule excluded direct and indirect remuneration fee reform.
Study Identifies Potential Biomarkers for De-escalating Chemotherapy in HER2-Positive Breast Cancer
Certain HER2-positive breast cancers may benefit from anti-HER2 therapy alone without the need for chemotherapy.
Trending News Today: AbbVie to Acquire Allergan for $63 Billion
Methemoglobinemia: Quick Diagnosis Key
Removal of the offending agent(s) is the first step in treatment for acquired methemoglobinemia.
FDA Issues Warnings to 2 Companies Marketing and Distributing Kratom Products
The letters request actions to correct violations cited by the agency.
Enlisting Pharmacists for HIV Prevention
Due to physician shortages, pharmacists represent a new avenue to increase accessibility to antivirals.
AbbVie Agrees to Acquire Allergan with $63B Deal
Announced by both companies today, the new combined company will consist of franchises across immunology, hematologic oncology, medical aesthetics, neuroscience, women’s health, eye care, and virology.
An independent review of pharmacy benefit managers (PBMs) in Ohio indicates that PBM pricing practices likely contribute to rising health care costs.
Generic Influenza Therapy Receives FDA Approval
The approved product is therapeutically equivalent to Genentech’s Tamiflu I Capsules, 30 mg, 45 mg, and 75 mg.
Interim Data Show Promising Efficacy of Cerdulatinib in Relapsed, Refractory Follicular Lymphoma
A phase 2a study is evaluating cerdulatinib, an oral SYK/JAK inhibitor, in pre-treated patients with relapsed/refractory follicular lymphoma.
Trending News Today: Trump Administration Seeks to Require Disclosure of Health Care Costs
FDA OKs New Pre-Filled Syringe for Lanreotide
The new syringe is designed to improve the subcutaneous administration of lanreotide (Somatuline Depot, Ipsen Biopharmaceuticals).
Transitions of Care Pharmacy Education May Lower Readmission Rates for Patients with COPD
Based on this analysis, a standardized TOC pharmacy education program for COPD was implemented at Rhode Island Hospital in late 2018.
FDA Grants Priority Review to Niraparib for Late-Stage Ovarian Cancer
The supplemental New Drug Application supports the expansion of niraparib’s indication as a late-line therapeutic option for patients with ovarian cancer.
Real-World Analysis Shows Targeted Therapies Can Benefit Older Patients with Kidney Cancer
Compared with nontargeted therapy, targeted therapies demonstrated a survival advantage for patients 65 years and older with metastatic renal cell carcinoma.
Retail Pharmacy Provides More Drug Disposal Options
In an effort to combat the opioid epidemic, Walgreens has introduced its recently announced an addition to its drug disposal program in the form of DisposeRx packets.
Monday Pharmaceutical Mystery: June 24
Why did the doctor lower this patient's gabapentin dose?
CDC Study Shows Rotavirus Vaccine Caused a Decline in Infection Cases
Rotavirus is a contagious viral infection causing gastroenteritis that generally affects infants and young children.
T-Cell Therapy Approach Shows Potential as Cure for Chronic Hepatitis B Virus
Receptor-modified T cells successfully controlled chronic hepatitis B virus, showing promise as a potential cure for the disease.
Trending News Today: ICER Recommends Lower Price for MS Drug Siponimod
New Treatment for HSDD Granted FDA Approval for Premenopausal Women
The effectiveness and safety of bremelanotide were studied in a pair of 24-week, randomized, double-blind, placebo-controlled trials in 1247 premenopausal women with acquired, generalized HSDD.
